As the Regulatory Affairs Specialist for the IMPACT Clinical Trial Accelerator Program, Pamela is the primary contact for life science start up companies, regarding domestic and foreign regulatory documentation, requirements, and procedures relating to pre-market regulatory approvals. Pamela draws on previous experience in preclinical and clinical research, in combination with expertise in entrepreneurial startups and small to medium size companies to balance risk management and regulatory compliance.
Expertise and background:
- Ph.D. Biochemistry, University of Windsor
- Lead author of 7 peer-reviewed journal articles
- Scientific Writer, Canadian Academy of Health Sciences, Assessment on Autism
- Senior Research Scientist, Advanced Orthomolecular Research